Permitify vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionPermitifyIsomorphic Labs
Pricing$297 per review (flat fee, no sub)Contact for pricing (partnership model)
Target UserArchitects, engineers, contractorsLarge pharma companies
Key TechnologyAI pre-submittal plan review vs city codesAlphaFold-based drug design engine
Latest NewsNo recent newsSeries B in Feb 2026; J&J collab in Jan 2026
IntegrationsNone (standalone upload)None (partnership-based)
Delivery1-3 hour turnaround, PDF/link reportCustom project timelines

Permitify and Isomorphic Labs serve completely different markets. Permitify is a ready-to-use, per-review AI tool for building compliance at $297/review — ideal for architects and engineers who need fast, city-code checks. Isomorphic Labs is a high-end pharma R&D partner leveraging AlphaFold for drug discovery, with no public pricing and a partnership-only model. Choose Permitify if you submit building plans; choose Isomorphic Labs if you're a large pharma company seeking AI-driven drug design.

Permitify
Permitify

AI pre-submittal plan review that catches city comments before you submit.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Paid
Contact Sales
Plans
$297/review
Popularity
2 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
Categories
👷 Construction & Field Service
🧬 Drug Discovery & Life Sciences
Features
AI pre-submittal plan review
Checks city ordinances and engineering standards
Reviews owner requirements, MDAs, variances, deviations
Reviews prior comments and firm standards
Identifies likely city comments, missing items, conflicts
Finds requirement gaps before submittal
Findings cited to specific code sections and sheet/page references
Priority-ranked issues with suggested next steps
Shareable report (PDF/link) for team, owner, engineer
Typical turnaround of 1–3 hours
No account or login required to start review
Flat fee per review — no subscription or contract
Full refund + $30 lunch guarantee
Free re-review of updated plans (June 2026 launch offer)
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: Permitify vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Permitify

0 mentions · mixed

What users praise

  • Flat fee of $297 per review, no subscription required.
  • No account or login needed to start a review.
  • Full refund plus $30 lunch credit satisfaction guarantee.
  • Fast turnaround of 1–3 hours for a single review.

What frustrates them

  • No user reviews or community feedback to gauge reliability.
  • Unproven accuracy in interpreting complex local codes.
  • Limited to pre-submittal review only; not a full design tool.
  • No integrations with BIM, CAD, or project management software.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Architect submitting building permits
    Pick: Permitify

    Permitify checks plans against city ordinances and engineering standards, catching likely city comments before submission — exactly what an architect needs.

  • Civil engineer in a small firm
    Pick: Permitify

    No subscription required; flat $297 per review fits small firm budgets. Free re-review of updated plans for June orders.

  • Large pharma company seeking AI-driven drug discovery
    Pick: Isomorphic Labs

    Isomorphic Labs offers AlphaFold-based predictive and generative models for protein-ligand interactions, with proven partnerships (Novartis, J&J) and recent Series B funding.

  • Developer reducing re-review cycles
    Pick: Permitify

    Permitify's priority-ranked issues and cited code sections help avoid costly city re-review fees.

  • Research institution exploring digital biology
    Pick: Isomorphic Labs

    Isomorphic Labs works with pharma partners for large-scale programs; ideal for institutions that can engage in deep collaborations.

Frequently Asked Questions

Permitify vs Isomorphic Labs: which should you choose?

Permitify and Isomorphic Labs serve completely different markets. Permitify is a ready-to-use, per-review AI tool for building compliance at $297/review — ideal for architects and engineers who need fast, city-code checks. Isomorphic Labs is a high-end pharma R&D partner leveraging AlphaFold for drug discovery, with no public pricing and a partnership-only model. Choose Permitify if you submit building plans; choose Isomorphic Labs if you're a large pharma company seeking AI-driven drug design.

What is Permitify's pricing model?

Flat fee of $297 per review, no subscription or contract. Includes free re-review of updated plans for orders before June 30, 2026.

Does Isomorphic Labs have a public pricing page?

No. Isomorphic Labs uses a partnership model with custom pricing. Contact them for details.

Can I use Permitify without an account?

Yes, no account or login required to start a review.

What is Isomorphic Labs' latest funding news?

Raised $600M external investment in 2025 and a Series B in February 2026 (undisclosed amount).

How fast does Permitify deliver results?

Typical turnaround of 1–3 hours after uploading plans.

Which pharma companies does Isomorphic Labs partner with?

Novartis and Johnson & Johnson (J&J collaboration announced Jan 2026).

Does Permitify integrate with CAD or project management software?

No, Permitify is a standalone upload-based tool.

Is Isomorphic Labs suitable for small biotech startups?

Not recommended; it focuses on large-scale partnerships with major pharma companies.

More Permitify or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026